Evidence map›Paper›PMID 27120484›Full record

ArticleJAMA dermatology2016

Psoriasis, Type 2 Diabetes Mellitus, and Obesity: Weighing the Evidence.

Joel M Gelfand

Abstract readEditorialComment
In one paragraph

Article in JAMA dermatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Psoriatic Disease in the US Latino Population: A Comprehensive Review.American journal of clinical dermatology · 2020
    Review
  7. Article
  8. Neutrophils in Psoriasis.Frontiers in immunology · 2019
    Review
  9. Article
  10. Psoriasis and the risk of diabetes: A prospective population-based cohort study.Journal of the American Academy of Dermatology · 2018
    Article
  11. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2017
    Article
  12. Diabetes mellitus and the skin.Reviews in endocrine & metabolic disorders · 2016
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Joel M GelfandDepartment of Dermatology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia.

Funding

Psoriasis and the Risk of DiabetesK24AR064310 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI GELFAND, JOEL M · 2013 to 2017
$870k
NIAMS NIH HHS K24 AR064310
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 2ObesityDiabetes MellitusHumansPsoriasisRisk Factors

Identifiers

PMID27120484
PMCPMC5291125

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.